BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osborne AL, Solowij N, Babic I, Lum JS, Newell KA, Huang XF, Weston-Green K. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2019;95:109666. [PMID: 31202911 DOI: 10.1016/j.pnpbp.2019.109666] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Rieger NS, Ng AJ, Lee S, Brady BH, Christianson JP. Maternal immune activation alters social affective behavior and sensitivity to corticotropin releasing factor in male but not female rats. Hormones and Behavior 2023;149:105313. [DOI: 10.1016/j.yhbeh.2023.105313] [Reference Citation Analysis]
2 Lagatta DC, Fassini A, Terzian AL, Corrêa FMA, Resstel LBM. The medial prefrontal cortex and the cardiac baroreflex activity: physiological and pathological implications. Pflugers Arch 2023. [PMID: 36695881 DOI: 10.1007/s00424-022-02786-5] [Reference Citation Analysis]
3 Fabris D, Carvalho MC, Brandão ML, Prado WA, Zuardi AW, Crippa JA, de Oliveira AR, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. J Psychopharmacol 2022;36:1371-83. [PMID: 36239039 DOI: 10.1177/02698811221125440] [Reference Citation Analysis]
4 Su Y, Lian J, Chen S, Zhang W, Deng C. Epigenetic histone acetylation modulating prenatal Poly I:C induced neuroinflammation in the prefrontal cortex of rats: a study in a maternal immune activation model. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1037105] [Reference Citation Analysis]
5 Visini G, Brown S, Weston-green K, Shannon Weickert C, Chesworth R, Karl T. The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1010478] [Reference Citation Analysis]
6 Pacheco ALD, de Melo IS, de Araujo Costa M, Amaral MMC, de Gusmão Taveiros Silva NK, Santos YMO, Gitaí DLG, Duzzioni M, Borbely AU, Silva RS, Donatti ALF, Mestriner L, Fuzo CA, Cummings RD, Garcia-Cairasco N, Dias-Baruffi M, de Castro OW. Neuroprotective Effect of Exogenous Galectin-1 in Status Epilepticus. Mol Neurobiol 2022. [PMID: 36171480 DOI: 10.1007/s12035-022-03038-4] [Reference Citation Analysis]
7 Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology (Berl) 2022. [PMID: 35904579 DOI: 10.1007/s00213-022-06196-4] [Reference Citation Analysis]
8 Rieger NS, Ng AJ, Lee S, Brady BH, Christianson JP. Maternal immune activation alters social affective behavior and sensitivity to corticotropin releasing factor in male but not female rats.. [DOI: 10.1101/2022.07.05.498833] [Reference Citation Analysis]
9 Białoń M, Wąsik A. Advantages and Limitations of Animal Schizophrenia Models. Int J Mol Sci 2022;23:5968. [PMID: 35682647 DOI: 10.3390/ijms23115968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen S, Lian J, Su Y, Deng C. Effects of Risperidone and Prenatal Poly I:C Exposure on GABAA Receptors and AKT-GSK3β Pathway in the Ventral Tegmental Area of Female Juvenile Rats. Biomolecules 2022;12:732. [PMID: 35625659 DOI: 10.3390/biom12050732] [Reference Citation Analysis]
11 Ganesh S, Cortes-Briones J, Schnakenberg Martin AM, Skosnik PD, D'Souza DC, Ranganathan M. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior. Cannabis Cannabinoid Res 2022. [PMID: 35319274 DOI: 10.1089/can.2021.0166] [Reference Citation Analysis]
12 Bagheri F, Safari A, Namavar MR. Effect of dimethyl fumarate on the changes in the medial prefrontal cortex structure and behavior in the poly(I:C)-induced maternal immune activation model of schizophrenia in the male mice. Behav Brain Res 2022;417:113581. [PMID: 34530042 DOI: 10.1016/j.bbr.2021.113581] [Reference Citation Analysis]
13 Zhang S, Li M, Guo Z. Effect of cannabidiol on schizophrenia based on randomized controlled trials: A meta-analysis. Annales Médico-psychologiques, revue psychiatrique 2021. [DOI: 10.1016/j.amp.2021.09.019] [Reference Citation Analysis]
14 Vallée A, Lecarpentier Y, Vallée JN. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway. Mol Psychiatry 2021. [PMID: 33837269 DOI: 10.1038/s41380-021-01086-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma. Int J Mol Sci 2021;22:3798. [PMID: 33917605 DOI: 10.3390/ijms22073798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Babic I, Sellers D, Else PL, Nealon J, Osborne AL, Pai N, Weston-Green K. Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats. J Psychopharmacol 2021;35:284-302. [PMID: 33570012 DOI: 10.1177/0269881120981377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA, Hallak JEC, Abílio VC. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders? Front Pharmacol 2020;11:635763. [PMID: 33613289 DOI: 10.3389/fphar.2020.635763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zou M, Liu Y, Xie S, Wang L, Li D, Li L, Wang F, Zhang Y, Xia W, Sun C, Wu L. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open Biol 2021;11:200306. [PMID: 33529552 DOI: 10.1098/rsob.200306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
19 García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. Biomolecules 2020;10:E1575. [PMID: 33228239 DOI: 10.3390/biom10111575] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 15.7] [Reference Citation Analysis]
20 Chye Y, Kirkham R, Lorenzetti V, McTavish E, Solowij N, Yücel M. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:627-35. [PMID: 32948510 DOI: 10.1016/j.bpsc.2020.07.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Borgan F, Kokkinou M, Howes O. The Cannabinoid CB1 Receptor in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:646-59. [PMID: 33077399 DOI: 10.1016/j.bpsc.2020.06.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Banaszkiewicz I, Biala G, Kruk-Slomka M. Contribution of CB2 receptors in schizophrenia-related symptoms in various animal models: Short review. Neurosci Biobehav Rev 2020;114:158-71. [PMID: 32437746 DOI: 10.1016/j.neubiorev.2020.04.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
23 Bauman MD, Van de Water J. Translational opportunities in the prenatal immune environment: Promises and limitations of the maternal immune activation model. Neurobiol Dis 2020;141:104864. [PMID: 32278881 DOI: 10.1016/j.nbd.2020.104864] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
24 Menne V, Chesworth R. Schizophrenia and drug addiction comorbidity: recent advances in our understanding of behavioural susceptibility and neural mechanisms. nab 2020;2:e10. [DOI: 10.35430/nab.2020.e10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]